Acute promyelocytic leukemia in a patient with multiple sclerosis following treatment with mitoxantrone

@article{Novoselac2004AcutePL,
  title={Acute promyelocytic leukemia in a patient with multiple sclerosis following treatment with mitoxantrone},
  author={Amory V Novoselac and Swathi Reddy and Jasotha Sanmugarajah},
  journal={Leukemia},
  year={2004},
  volume={18},
  pages={1561-1562}
}
Therapy-related acute myeloid leukemia (tAML) has been well described following use of chemotherapeutic agents for treatment of malignant and less often nonmalignant diseases. Treatment of multiple sclerosis (MS), an autoimmune central nervous system disease with a variable clinical course, most often with a gradual decline in neurologic function, has included the use of chemotherapeutic agents, such as methotrexate and mitoxantrone. In recent years, rare reports have indicated the occurrence… CONTINUE READING